levofloxacin has been researched along with Kahler Disease in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 4 (30.77) | 2.80 |
Authors | Studies |
---|---|
Jain, A; Jandial, A; Khadwal, A; Lad, D; Malhotra, P; Prakash, G; Ray, P; Sachdeva, MUS; Singh, C; Sreedharanunni, S; Suri, V; Varma, N; Varma, S | 1 |
Belsham, E; Bowcock, S; Campbell, G; Dawkins, B; Dignum, H; Drayson, MT; Dunn, JA; Hamblin, M; Harrison, B; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Karunanithi, K; Lokare, A; Low, E; Meads, D; Monahan, I; Neilson, J; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K | 1 |
Ramasamy, K | 1 |
Bowcock, S; Dawkins, B; Drayson, MT; Dunn, JA; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Low, E; Meads, D; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K | 1 |
Harrison, SJ; Slavin, MA; Teh, BW; Thursky, KA; Worth, LJ | 1 |
Albrich, WC; Boggian, K | 1 |
Bowcock, S; Drayson, MT; Dunn, JA; Iqbal, G; Planche, T; Pratt, G; Yong, K | 1 |
Copeland, V; McLaughlin, M; Trifilio, S | 1 |
Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M | 1 |
Ahn, JS; Jang, HC; Jung, SH; Kang, SJ; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Yang, DH | 1 |
Babalola, O; Baird, P; Devoe, CE; Hoang, H; Jhaveri, KD; Leung, S; Wanchoo, R | 1 |
Gergis, U; Jacobs, SE; Mark, TM; Satlin, MJ; Shore, TB; Soave, R; Vardhana, S; Walsh, TJ | 1 |
Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H | 1 |
3 trial(s) available for levofloxacin and Kahler Disease
Article | Year |
---|---|
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Prospective Studies | 2019 |
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridioides difficile; Cost-Benefit Analysis; Cross Infection; England; Female; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Northern Ireland; Technology Assessment, Biomedical; Wales | 2019 |
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Topics: Amyloidosis; Anemia, Aplastic; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Middle Aged; Multiple Myeloma; Neutropenia; Ofloxacin | 2005 |
10 other study(ies) available for levofloxacin and Kahler Disease
Article | Year |
---|---|
Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Topics: Adult; Aged; Antibiotic Prophylaxis; Female; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Transplantation, Autologous | 2023 |
Reducing infection-related morbidity and mortality in patients with myeloma.
Topics: Diphosphonates; Double-Blind Method; Humans; Infections; Levofloxacin; Multiple Myeloma | 2019 |
Levofloxacin prophylaxis in patients with myeloma.
Topics: Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Humans; Levofloxacin; Multiple Myeloma | 2020 |
Levofloxacin prophylaxis in patients with myeloma.
Topics: Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Humans; Levofloxacin; Multiple Myeloma | 2020 |
Levofloxacin prophylaxis in patients with myeloma - Authors' reply.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Humans; Levofloxacin; Multiple Myeloma | 2020 |
Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Retrospective Studies | 2018 |
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies | 2014 |
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Comorbidity; Female; Humans; Incidence; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Pyrazines; Treatment Outcome | 2014 |
A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Levofloxacin; Multiple Myeloma; Thalidomide | 2016 |
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Female; Filgrastim; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Levofloxacin; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous | 2015 |